#None #Levi & Korsinsky #Securities Fraud #Hims & Hers

Important Update for Hims & Hers Health, Inc. Investors

Investors in Hims & Hers Health, Inc. should take note: Levi & Korsinsky, LLP is officially notifying shareholders about a class action lawsuit pertaining to alleged securities fraud. This action involves a significant timeline, particularly for those who were impacted by this scandal between April 29, 2025, and June 23, 2025.

Key Details of the Class Action Lawsuit

The lawsuit is focused on recovering losses for investors who were adversely affected by alleged misleading statements and actions taken by Hims & Hers Health, Inc. The class action has been defined specifically within the context of these dates, emphasizing the importance of timely legal action. As of now, shareholders are encouraged to stay informed about their potential participation in this legal action before the crucial lead plaintiff deadline of August 25, 2025.

The specific accusations against the company include claims that Hims & Hers engaged in deceptive practices, promoting unsafe products that jeopardized patient safety. Reports allege that during this period, the company was involved in selling unauthorized versions of Wegovy®, a medication used in weight management, which potentially put countless consumers at risk.

What Constitutes a Lead Plaintiff?

The position of a lead plaintiff is vital in collective lawsuits, as those occupying this role can significantly influence the case's direction and potential outcome. If any investors experienced losses during the defined timeframe, they have the right to request to be appointed as leads in this case. However, it is essential to clarify that participating in the lawsuit as a class member does not necessitate taking on the lead plaintiff role.

Next Steps for Investors

To move forward and ensure your voice is heard, those affected by this timeline can submit their requests for lead plaintiff status through Levi & Korsinsky’s dedicated platform. This process is to ensure everyone gets the necessary information and communication regarding this potentially pivotal lawsuit. Interested parties may also directly contact Joseph E. Levi, Esq. at his email or phone number provided in official documents to get additional clarification or guidance.

No Financial Obligation

One of the significant aspects of this lawsuit that should alleviate investor apprehension is the fact that participants are entitled to potential compensation without incurring any upfront costs or fees. The law firm emphasizes that engaging in this class action does not equate to any financial risk for the investors.

Why Choose Levi & Korsinsky?

The law firm brings extensive experience and a proven track record in securities litigation, having settled literally hundreds of millions for shareholders over the past two decades. Ranking consistently among the top firms for securities class action cases in the United States, they have structured their approach to ensure their clients obtain the justice they deserve following any form of financial malfeasance.

Concluding Thoughts

With the deadline for lead plaintiff requests approaching, Hims & Hers Health investors need to be aware of their rights and options in this lawsuit. Being informed is crucial to navigate complex legal terrain following reported incidents of alleged fraud. Maintaining proactive engagement could ultimately safeguard shareholder interests and enhance the likelihood of recovering losses sustained as a result of corporate misconduct. Interested parties are encouraged to reach out and ensure they do not miss this critical opportunity to seek redress.

For additional information, you can visit the official Levi & Korsinsky website or contact their office directly to stay updated and informed regarding further developments in this ongoing case.